Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery

NCT03849443 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

604

Enrollment

OTHER

Sponsor class

Conditions

Open Posterior Thoracolumbar Spinal Fusion Procedure

Interventions

DRUG: Tranexamic Acid Injectable Product (1000 mg intravenous bolus)
DRUG: Vitamin C 250 MG Oral Tablet
DRUG: Tranexamic Acid 650Mg Tablet

Sponsor

Rush University Medical Center